Beam Benefits Recognized As One of Inc. 5000’s Fastest Growing Companies
August 16, 2022 13:23 ET
|
Beam Benefits
COLUMBUS, Ohio, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Beam Benefits, the digitally-native employee benefits company, today announced its ranking (No. 808) on the 2022 Inc. 5000, a list of the nation’s...
OJO Labs Named to Inc. Magazine’s List of Fastest-Growing Private Companies for Second Consecutive Year
August 16, 2022 08:46 ET
|
OJO Labs
AUSTIN, Texas, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Today, Inc. revealed that OJO Labs, for the second year in a row, was named on its annual Inc. 5000 list at No. 355. The most prestigious ranking of...
Xevant Ranks No. 1 on the Inc. 5000 2022 List as the Fastest Growing Private Software Company in America
August 16, 2022 08:00 ET
|
Xevant, Inc.
LEHI, Utah, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Today, Inc. revealed that Xevant is No. 28 on its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in...
Space Situational Awareness Services Market - A Global and Regional Analysis: Focus on End User, Orbit, Service, and Region - Analysis and Forecast, 2022-2032
July 13, 2022 06:20 ET
|
ReportLinker
New York, July 13, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Space Situational Awareness Services Market - A Global and Regional Analysis: Focus on End User,...
First Orion Named as an Inc. Magazine’s Best Workplaces for 2022
May 10, 2022 13:09 ET
|
First Orion Corp.
NORTH LITTLE ROCK, Ark. , May 10, 2022 (GLOBE NEWSWIRE) -- First Orion has been named to Inc. magazine’s annual Best Workplaces list. Featured in the May/June 2022 issue, hitting newsstands on May...
With a Two-Year Revenue Growth of 803%, OJO Labs Ranks No. 16 on Inc. Magazine’s List of the Southwest Region’s Fastest-Growing Private Companies
March 15, 2022 16:03 ET
|
OJO Labs
AUSTIN, Texas, March 15, 2022 (GLOBE NEWSWIRE) -- Inc. magazine today revealed that OJO Labs is No. 16 on its third annual Inc. 5000 Regionals Southwest list, the most prestigious ranking of the...
Qualigen Therapeutics CEO Michael Poirier Provides Letter to Shareholders
February 22, 2022 09:15 ET
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers...
Data from Qualigen Therapeutics’ Lead Program QN-302 Accepted as Three Poster Presentations at AACR 2022 Conference
February 15, 2022 09:15 ET
|
Qualigen Therapeutics, Inc.
Posters to be Presented During the In-Person Conference Being Held April 8-13, 2022 in New Orleans CARLSBAD, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq:...
Qualigen Therapeutics Engages Professor Stephen Neidle as Scientific Advisor in the Development of Lead Program QN-302
February 01, 2022 09:15 ET
|
Qualigen Therapeutics, Inc.
Innovator Behind Pancreatic Cancer-Focused Program Becomes Scientific Advisor CARLSBAD, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology...
Qualigen Therapeutics Secures Worldwide Rights to G4-Selective Transcription Inhibitors from University College London to Develop as Cancer Therapeutics
January 18, 2022 09:15 ET
|
Qualigen Therapeutics, Inc.
Preclinical Therapeutic Program to Be Initially Focused on Pancreatic Cancer CARLSBAD, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology...